EUCALIA Inc
TSE:286A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (15.3), the stock would be worth ¥-701.02 (180% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -19.2 | ¥879 |
0%
|
| Industry Average | 15.3 | ¥-701.02 |
-180%
|
| Country Average | 11.5 | ¥-523.73 |
-160%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
EUCALIA Inc
TSE:286A
|
31.4B JPY | -19.2 | 11.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.6B USD | 9.4 | 56.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 8.3 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.4B USD | 0 | 12.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 8.5 | 23.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 8.8 | 18 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 11.8 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 13.2 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 4 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -62.6 | -27.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 5.5 | 13.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 8 |
| Median | 11.5 |
| 70th Percentile | 16 |
| Max | 277 515 329.3 |
Other Multiples
EUCALIA Inc
Glance View
EUCALIA, Inc. engages in the elderly care, hospital management and operations, and medical tourism businesses. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 833 full-time employees. The company went IPO on 2024-12-12. The company operates through three segments. The Medical Management Comprehensive Support Business segment provides comprehensive support for issues faced by affiliated medical corporations, including management consulting, personnel recruitment support, digital transformation (DX) support, and fundraising support. The Senior Related Business segment provides nursing care services such as the operation of nursing care facilities, as well as consultation on admission to nursing care facilities and facility introduction services. The Highly Controlled Medical Device Business segment manufactures and sells contact lenses. The company also provides treatment progress data analysis and sales activity support services for pharmaceutical companies. Through its subsidiaries, it is also engaged in venture investment, as well as the provision of brain checkup services, and real estate buying and selling services.
